Natural killer cells sound menacing, but they play a friendly role in keeping us healthy. And they might do much more in stopping cancer.
After years of diligent, groundbreaking research, MD Anderson physician-scientists are putting natural killer cells – NK cells for short – to work in a series of clinical trials for a variety of cancers through the cancer center’s Moon Shots Program™.
“These white...
When Jo Ann West learned she had early-stage breast cancer, her doctor suggested an inventive new treatment that involves no major surgery...
After all 13 breast cancer patients in a first-of-its-kind clinical trial responded positively to a new targeted therapy, MD Anderson researchers...
Two new clinical trials at MD Anderson are taking aim at mantle cell lymphoma – a rare form of non-Hodgkin’s lymphoma.
Most mantle cell lymphoma trials test new treatments on patients with relapsed disease, but MD Anderson’s trials are focusing on patients who are newly diagnosed.
“The first therapy is the most important,” said Michael Wang, M.D., professor of Lymphoma and Myeloma and the trial’s principal investigator...
Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as...
What if you or a loved one had cancer but were denied access to a research study testing a poten-tially beneficial treatment?
This...
There are many moving parts when it comes to the mechanics of how otherwise healthy cells are transformed into those that cause deadly cancers...
More than 50 years after the U.S. Surgeon General first warned about the dangers of cigarettes, smoking rates have plummeted.
For decades, combination chemotherapy has been the main treatment for patients with acute myeloid leukemia (AML) – an aggressive cancer of...
New initiatives to improve the treatment of pancreatic cancer have earned two early-career investigators at MD Anderson multi-year support...